1. Dhariwal NK, Lynde GC. Update in the management of patients with preeclampsia. Anesthesiol Clin. 2017; 35:95–106.
Article
2. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992; 99:547–553.
Article
3. Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009; 33:196–205.
Article
4. DeGroot LJ, Jameson JL. Endocrinology. 5th ed. Philadelphia (PA): Elsevier Saunders;2006.
5. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001; 86:5210–5216.
Article
6. Snabboon T, Plengpanich W, Houngngam N, Buranasupkajorn P, Plengvidhya N, Sereepapong W, et al. Concurrent bilateral pheochromocytoma and thoracic paraganglioma during pregnancy. Endocrine. 2010; 37:261–264.
Article
7. Harrington JL, Farley DR, van Heerden JA, Ramin KD. Adrenal tumors and pregnancy. World J Surg. 1999; 23:182–186.
Article
8. Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg. 2013; 100:182–190.
Article
9. Lenders JW. Pheochromocytoma and pregnancy: a deceptive connection. Eur J Endocrinol. 2012; 166:143–150.
10. Lyman DJ. Paroxysmal hypertension, pheochromocytoma, and pregnancy. J Am Board Fam Pract. 2002; 15:153–158.
11. Prete A, Paragliola RM, Salvatori R, Corsello SM. Management of catecholamine-secreting tumors in pregnancy: a review. Endocr Pract. 2016; 22:357–370.
Article
12. Al-Harthy M, Al-Harthy S, Al-Otieschan A, Velagapudi S, Alzahrani AS. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas. Endocr Pract. 2009; 15:194–202.
Article
13. Øian P, Kjeldsen SE, Eide I, Maltau JM. Increased arterial catecholamines in pre-eclampsia. Acta Obstet Gynecol Scand. 1986; 65:613–617.
Article
14. Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, et al. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol (Oxf). 2006; 65:186–190.
Article
15. Feek CM, Earnshaw PM. Hypertensive response to labetalol in phaeochromocytoma. BMJ. 1980; 281:387.
Article